Do not forget your beginner's heart
Release time:
2022-08-04
Recently, the "Koizumi Chopper Shooting Garlic " incident on the Internet has caused a lot of uproar. A consumer claimed that he used the newly bought Zhang Xiaoquan kitchen knife to shoot garlic, and the kitchen knife broke. The consumer contacted Zhang Xiaoquan's customer service, who said that this knife "does not recommend taking garlic " , and responded that garlic could not be taken under questioning. The consumer could not accept it, so he sent the chat screenshots to the Internet and quickly boarded the hot search. The storm of
"shooting garlic " immediately attracted a lot of attention. Netizens also found out that General Manager Zhang Xiaoquan once said in the program that the Chinese cut vegetables in the wrong way. Zhang Xiaoquan quickly apologized, popularized the usage of "correct " of the popular science kitchen knife, popularized the relationship between kitchen knife hardness and fracture, gave any Zhang Xiaoquan kitchen knife free of charge to consumers who suffered losses in this incident, and issued "broken knife call order " promising to replace the broken knife within .
From the perspective of the service industry, Zhang Xiaoquan's response is really good, but even if customer service has explained in detail the material and function of the knife, the response of "cannot shoot garlic " is still unacceptable to many people. We all know that there are specialties in the technical industry, and it is normal for the functions and characteristics of the products to be different. However, the knives used to make Chinese dishes cannot be patted with garlic and ginger, and even the most basic ingredients cannot be handled, which is really surprising. Just like a rocket expert, he may know nothing about cement production, but basic mathematical calculations will always be. Tell him the daily output of the cement plant and let him calculate the annual output. Is it okay?
can't help but remind me of the workplace. Everyone has different majors. The job they find after graduation may not be the professional counterpart, but the sense of responsibility is the most basic and necessary. The mistakes in work can be attributed to their lack of professional level, but a correct working attitude and sense of responsibility for their own work cannot be missing. The enterprise is a big family, but the "family " in it has no blood relationship. to be exact, everyone is a community of interests. blood relatives can tolerate your willfulness and mistakes, but entrepreneurs can't do it, because they come to the big family of the enterprise to earn the confidence to tolerate blood relatives. Family members can share weal and woe at work, but no one is obligated or willing to pay for your mistakes.
No matter what you do, your professional skills should be continuously improved, but your basic duties should not be forgotten. (Shang Yongzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page